NeuroMetrix Company Profile (NASDAQ:NURO)

About NeuroMetrix (NASDAQ:NURO)

NeuroMetrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NURO
  • CUSIP: N/A
  • Web: www.neurometrix.com
Capitalization:
  • Market Cap: $3.63 million
  • Outstanding Shares: 2,126,000
Average Prices:
  • 50 Day Moving Avg: $1.99
  • 200 Day Moving Avg: $2.08
  • 52 Week Range: $0.38 - $4.50
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: -0.01
Sales & Book Value:
  • Annual Revenue: $15.72 million
  • Price / Sales: 0.23
  • Book Value: $2.83 per share
  • Price / Book: 0.60
Profitability:
  • EBITDA: ($13,270,000.00)
  • Net Margins: -83.92%
  • Return on Equity: -209.56%
  • Return on Assets: -135.03%
Debt:
  • Current Ratio: 2.13%
  • Quick Ratio: 1.73%
Misc:
  • Average Volume: 62,842 shs.
  • Beta: 0.41
  • Short Ratio: 1.7
 

Frequently Asked Questions for NeuroMetrix (NASDAQ:NURO)

What is NeuroMetrix's stock symbol?

NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."

When did NeuroMetrix's stock split? How did NeuroMetrix's stock split work?

NeuroMetrix shares reverse split on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.

How were NeuroMetrix's earnings last quarter?

NeuroMetrix, Inc. (NASDAQ:NURO) released its earnings results on Thursday, July, 21st. The company reported ($42.96) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($7.44) by $35.52. The company earned $2.65 million during the quarter, compared to analyst estimates of $1.22 million. NeuroMetrix had a negative net margin of 83.92% and a negative return on equity of 209.56%. View NeuroMetrix's Earnings History.

Where is NeuroMetrix's stock going? Where will NeuroMetrix's stock price be in 2017?

1 brokers have issued twelve-month price objectives for NeuroMetrix's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate NeuroMetrix's stock price to reach $3.00 in the next twelve months. View Analyst Ratings for NeuroMetrix.

Who are some of NeuroMetrix's key competitors?

Who are NeuroMetrix's key executives?

NeuroMetrix's management team includes the folowing people:

  • Shai N. Gozani M.D., Ph.D., Chairman of the Board, President, Chief Executive Officer, Secretary
  • Thomas T. Higgins, Chief Financial Officer, Senior Vice President, Treasurer
  • Francis X. McGillin, Senior Vice President, General Manager - Consumer Wearables
  • David E. Goodman M.D., Independent Director
  • Allen J. Hinkle M.D., Independent Director
  • Nancy E. Katz, Independent Director
  • Timothy R. Surgenor, Independent Director
  • David Van Avermaete, Independent Director

How do I buy NeuroMetrix stock?

Shares of NeuroMetrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NeuroMetrix's stock price today?

One share of NeuroMetrix stock can currently be purchased for approximately $1.71.


MarketBeat Community Rating for NeuroMetrix (NASDAQ NURO)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  140
MarketBeat's community ratings are surveys of what our community members think about NeuroMetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NeuroMetrix (NASDAQ:NURO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (75.44% upside)
Consensus Price Target History for NeuroMetrix (NASDAQ:NURO)
Price Target History for NeuroMetrix (NASDAQ:NURO)
Analysts' Ratings History for NeuroMetrix (NASDAQ:NURO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/20/2017HC WainwrightReiterated RatingBuy$10.00 -> $3.00N/AView Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$36.00N/AView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for NeuroMetrix (NASDAQ:NURO)
Earnings by Quarter for NeuroMetrix (NASDAQ:NURO)
Earnings History by Quarter for NeuroMetrix (NASDAQ NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/2017Q2 2017($2.83)($2.49)$4.40 million$4.31 millionViewN/AView Earnings Details
4/20/2017Q1 2017($3.92)($7.28)$4.17 million$4.31 millionViewN/AView Earnings Details
1/26/2017Q416($6.00)($4.16)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($6.56)($6.08)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($7.44)($42.96)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($7.60)($8.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.64)($2.08)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($3.84)$9.80 million$1.22 millionViewListenView Earnings Details
2/12/2015Q414($2.88)$4.62 million$1.41 millionViewN/AView Earnings Details
7/24/2014Q413($6.80)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($6.96)ViewListenView Earnings Details
10/23/2013Q313($2.08)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($7.36)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($1.36)($1.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeuroMetrix (NASDAQ:NURO)
Next Year EPS Consensus Estimate: $-4.5 EPS

Dividends

Dividend History for NeuroMetrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for NeuroMetrix (NASDAQ:NURO)
Insider Ownership Percentage: 4.40%
Institutional Ownership Percentage: 6.53%
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)
Institutional Ownership by Quarter for NeuroMetrix (NASDAQ:NURO)
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2017Thomas T HigginsInsiderBuy1,000$2.83$2,830.00View SEC Filing  
6/16/2017Shai GozaniCEOBuy3,500$2.90$10,150.00View SEC Filing  
6/15/2017Thomas T HigginsInsiderBuy3,500$2.98$10,430.00View SEC Filing  
6/14/2017Shai GozaniCEOBuy5,000$2.97$14,850.00View SEC Filing  
6/14/2017Thomas T HigginsInsiderBuy2,300$2.97$6,831.00View SEC Filing  
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for NeuroMetrix (NASDAQ:NURO)
Latest Headlines for NeuroMetrix (NASDAQ:NURO)
Source:
Loading headlines, please wait.

Social

Chart

NeuroMetrix (NURO) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.